Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | ISO | Gcnt3 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GCNT3 mRNA] | CTD | PMID:31150632 | 1-naphthyl isothiocyanate | decreases expression | ISO | Gcnt3 (Rattus norvegicus) | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of GCNT3 mRNA | CTD | PMID:30723492 | 17beta-estradiol | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Estradiol results in increased expression of GCNT3 mRNA | CTD | PMID:20106945 and PMID:31614463 | 17beta-estradiol | multiple interactions | ISO | Gcnt3 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of GCNT3 mRNA | CTD | PMID:26496021 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GCNT3 mRNA | CTD | PMID:20106945 more ... | 6-propyl-2-thiouracil | increases expression | ISO | Gcnt3 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of GCNT3 mRNA | CTD | PMID:30047161 | acetamide | affects expression | ISO | Gcnt3 (Rattus norvegicus) | 6480464 | acetamide affects the expression of GCNT3 mRNA | CTD | PMID:31881176 | acrylamide | increases expression | ISO | Gcnt3 (Rattus norvegicus) | 6480464 | Acrylamide results in increased expression of GCNT3 mRNA | CTD | PMID:28959563 | adefovir pivoxil | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | adefovir dipivoxil results in increased expression of GCNT3 mRNA | CTD | PMID:25596134 | aflatoxin B1 | increases expression | ISO | Gcnt3 (Rattus norvegicus) | 6480464 | Aflatoxin B1 results in increased expression of GCNT3 mRNA | CTD | PMID:23630614 more ... | aflatoxin B1 | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of GCNT3 mRNA | CTD | PMID:27153756 | amitrole | increases expression | ISO | Gcnt3 (Rattus norvegicus) | 6480464 | Amitrole results in increased expression of GCNT3 mRNA | CTD | PMID:30047161 | ammonium chloride | affects expression | ISO | Gcnt3 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of GCNT3 mRNA | CTD | PMID:16483693 | antimony(0) | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Antimony results in increased expression of GCNT3 mRNA | CTD | PMID:17547211 | arsenous acid | decreases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of GCNT3 mRNA | CTD | PMID:21461292 | arsenous acid | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of GCNT3 mRNA | CTD | PMID:29095437 | arsenous acid | multiple interactions | EXP | | 6480464 | Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of GCNT3 mRNA] | CTD | PMID:29095437 | arsenous acid | decreases response to substance | ISO | GCNT3 (Homo sapiens) | 6480464 | GCNT3 protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:20707922 | azathioprine | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Azathioprine results in increased expression of GCNT3 mRNA | CTD | PMID:22623647 and PMID:26198647 | benzo[a]pyrene | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of GCNT3 mRNA | CTD | PMID:19737606 more ... | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of GCNT3 promoter | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | ISO | GCNT3 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of GCNT3 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene | decreases methylation | ISO | GCNT3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of GCNT3 3' UTR | CTD | PMID:27901495 | beta-naphthoflavone | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | beta-Naphthoflavone results in increased expression of GCNT3 mRNA | CTD | PMID:19737606 | bisphenol A | multiple interactions | ISO | Gcnt3 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of GCNT3 mRNA | CTD | PMID:26496021 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of GCNT3 mRNA | CTD | PMID:32156529 | bisphenol A | affects expression | ISO | GCNT3 (Homo sapiens) | 6480464 | bisphenol A affects the expression of GCNT3 mRNA | CTD | PMID:30903817 | bisphenol A | decreases expression | ISO | Gcnt3 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of GCNT3 mRNA | CTD | PMID:25181051 | cadmium dichloride | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of GCNT3 mRNA | CTD | PMID:25596134 | calcitriol | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of GCNT3 mRNA | CTD | PMID:16002434 | carnosic acid | decreases expression | EXP | | 6480464 | salvin results in decreased expression of GCNT3 protein | CTD | PMID:35926579 | CGP 52608 | multiple interactions | ISO | GCNT3 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to GCNT3 gene] | CTD | PMID:28238834 | chloroacetaldehyde | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | chloroacetaldehyde results in increased expression of GCNT3 mRNA | CTD | PMID:25596134 | chromium(6+) | affects expression | EXP | | 6480464 | chromium hexavalent ion affects the expression of GCNT3 mRNA | CTD | PMID:28472532 | cidofovir anhydrous | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Cidofovir results in increased expression of GCNT3 mRNA | CTD | PMID:25596134 | cisplatin | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of GCNT3 mRNA | CTD | PMID:27392435 | cisplatin | multiple interactions | ISO | GCNT3 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of GCNT3 mRNA | CTD | PMID:27392435 | cobalt atom | increases expression | EXP | | 6480464 | Cobalt results in increased expression of GCNT3 mRNA | CTD | PMID:34468815 | copper atom | multiple interactions | ISO | GCNT3 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of GCNT3 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | GCNT3 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of GCNT3 mRNA | CTD | PMID:20971185 | copper(II) sulfate | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of GCNT3 mRNA | CTD | PMID:19549813 | cyclosporin A | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of GCNT3 mRNA | CTD | PMID:20106945 more ... | cylindrospermopsin | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | cylindrospermopsin results in increased expression of GCNT3 mRNA | CTD | PMID:24921660 | dextran sulfate | multiple interactions | EXP | | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GCNT3 mRNA | CTD | PMID:29950665 | diarsenic trioxide | multiple interactions | EXP | | 6480464 | Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of GCNT3 mRNA] | CTD | PMID:29095437 | diarsenic trioxide | decreases response to substance | ISO | GCNT3 (Homo sapiens) | 6480464 | GCNT3 protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:20707922 | diarsenic trioxide | decreases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of GCNT3 mRNA | CTD | PMID:21461292 | diarsenic trioxide | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of GCNT3 mRNA | CTD | PMID:29095437 | diazinon | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Diazinon results in increased expression of GCNT3 mRNA | CTD | PMID:26198647 | diethyl maleate | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | diethyl maleate results in increased expression of GCNT3 mRNA | CTD | PMID:33545341 | diethylstilbestrol | decreases expression | ISO | Gcnt3 (Rattus norvegicus) | 6480464 | Diethylstilbestrol results in decreased expression of GCNT3 mRNA | CTD | PMID:21658437 | diethylstilbestrol | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Diethylstilbestrol results in increased expression of GCNT3 mRNA | CTD | PMID:26198647 | dioxygen | decreases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Oxygen deficiency results in decreased expression of GCNT3 mRNA | CTD | PMID:25596134 | dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Antimony Potassium Tartrate results in increased expression of GCNT3 mRNA | CTD | PMID:17547211 | disodium selenite | decreases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Sodium Selenite results in decreased expression of GCNT3 mRNA | CTD | PMID:18175754 | Ethyl acrylate | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | ethyl acrylate results in increased expression of GCNT3 mRNA | CTD | PMID:26198647 | fenofibrate | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Fenofibrate results in increased expression of GCNT3 mRNA | CTD | PMID:25596134 | fonofos | increases methylation | ISO | GCNT3 (Homo sapiens) | 6480464 | Fonofos results in increased methylation of GCNT3 promoter | CTD | PMID:22847954 | furan | increases expression | ISO | Gcnt3 (Rattus norvegicus) | 6480464 | furan results in increased expression of GCNT3 mRNA | CTD | PMID:26194646 and PMID:27387713 | genistein | decreases expression | EXP | | 6480464 | Genistein results in decreased expression of GCNT3 mRNA | CTD | PMID:22553218 | gentamycin | decreases expression | ISO | Gcnt3 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of GCNT3 mRNA | CTD | PMID:22061828 | hydrogen peroxide | affects expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of GCNT3 mRNA | CTD | PMID:20044591 and PMID:23410634 | ibuprofen | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Ibuprofen results in increased expression of GCNT3 mRNA | CTD | PMID:25596134 | indole-3-methanol | affects expression | ISO | Gcnt3 (Rattus norvegicus) | 6480464 | indole-3-carbinol affects the expression of GCNT3 mRNA | CTD | PMID:21396975 | isotretinoin | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Isotretinoin results in increased expression of GCNT3 mRNA | CTD | PMID:18769122 | lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of GCNT3 mRNA | CTD | PMID:21829687 | leflunomide | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | leflunomide results in increased expression of GCNT3 mRNA | CTD | PMID:28988120 | lipopolysaccharide | multiple interactions | ISO | GCNT3 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of GCNT3 mRNA | CTD | PMID:35811015 | menadione | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Vitamin K 3 results in increased expression of GCNT3 mRNA | CTD | PMID:23410634 | metformin | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Metformin results in increased expression of GCNT3 mRNA | CTD | PMID:25596134 | metformin | multiple interactions | EXP | | 6480464 | Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of GCNT3 mRNA] | CTD | PMID:29095437 | metformin | increases expression | ISO | Gcnt3 (Rattus norvegicus) | 6480464 | Metformin results in increased expression of GCNT3 mRNA | CTD | PMID:25596134 | methimazole | increases expression | ISO | Gcnt3 (Rattus norvegicus) | 6480464 | Methimazole results in increased expression of GCNT3 mRNA | CTD | PMID:30047161 | N-nitrosodimethylamine | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Dimethylnitrosamine results in increased expression of GCNT3 mRNA | CTD | PMID:17547211 | N-nitrosodimethylamine | decreases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Dimethylnitrosamine results in decreased expression of GCNT3 mRNA | CTD | PMID:26198647 | N-Nitrosopyrrolidine | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | N-Nitrosopyrrolidine results in increased expression of GCNT3 mRNA | CTD | PMID:32234424 | nickel dichloride | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | nickel chloride results in increased expression of GCNT3 mRNA | CTD | PMID:17547211 | O-methyleugenol | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | methyleugenol results in increased expression of GCNT3 mRNA | CTD | PMID:32234424 | ochratoxin A | decreases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | ochratoxin A results in decreased expression of GCNT3 mRNA | CTD | PMID:30559759 | ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of GCNT3 mRNA | CTD | PMID:31626304 and PMID:33026818 | para-Cresidine | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | cresidine results in increased expression of GCNT3 mRNA | CTD | PMID:26198647 | paracetamol | decreases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of GCNT3 mRNA | CTD | PMID:21420995 and PMID:29067470 | paracetamol | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of GCNT3 mRNA | CTD | PMID:22230336 | parathion | increases methylation | ISO | GCNT3 (Homo sapiens) | 6480464 | Parathion results in increased methylation of GCNT3 promoter | CTD | PMID:22847954 | phorbol 13-acetate 12-myristate | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of GCNT3 mRNA | CTD | PMID:26198647 | pirinixic acid | multiple interactions | ISO | GCNT3 (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GCNT3 mRNA | CTD | PMID:19710929 | potassium bromate | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | potassium bromate results in increased expression of GCNT3 mRNA | CTD | PMID:30559759 | quercetin | affects expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Quercetin affects the expression of GCNT3 mRNA | CTD | PMID:21632981 | reserpine | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Reserpine results in increased expression of GCNT3 mRNA | CTD | PMID:26198647 | resveratrol | multiple interactions | ISO | GCNT3 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of GCNT3 mRNA | CTD | PMID:23557933 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | GCNT3 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of GCNT3 mRNA | CTD | PMID:35811015 | silicon dioxide | decreases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Silicon Dioxide results in decreased expression of GCNT3 mRNA | CTD | PMID:25351596 | silver atom | increases expression | EXP | | 6480464 | Silver results in increased expression of GCNT3 mRNA | CTD | PMID:27131904 | silver(0) | increases expression | EXP | | 6480464 | Silver results in increased expression of GCNT3 mRNA | CTD | PMID:27131904 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of GCNT3 mRNA | CTD | PMID:36209798 | sotorasib | multiple interactions | ISO | GCNT3 (Homo sapiens) | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of GCNT3 mRNA | CTD | PMID:36139627 | sulfadimethoxine | increases expression | ISO | Gcnt3 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in increased expression of GCNT3 mRNA | CTD | PMID:30047161 | sulforaphane | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | sulforaphane results in increased expression of GCNT3 mRNA | CTD | PMID:31838189 | temozolomide | decreases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of GCNT3 mRNA | CTD | PMID:31758290 | terbufos | increases methylation | ISO | GCNT3 (Homo sapiens) | 6480464 | terbufos results in increased methylation of GCNT3 promoter | CTD | PMID:22847954 | tert-butyl hydroperoxide | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in increased expression of GCNT3 mRNA | CTD | PMID:23410634 | tetrachloromethane | increases expression | ISO | Gcnt3 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in increased expression of GCNT3 mRNA | CTD | PMID:31150632 | tetrachloromethane | multiple interactions | ISO | Gcnt3 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GCNT3 mRNA] | CTD | PMID:31150632 | titanium dioxide | multiple interactions | EXP | | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GCNT3 mRNA | CTD | PMID:29950665 | trametinib | multiple interactions | ISO | GCNT3 (Homo sapiens) | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of GCNT3 mRNA | CTD | PMID:36139627 | Tributyltin oxide | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | bis(tri-n-butyltin)oxide results in increased expression of GCNT3 mRNA | CTD | PMID:26198647 | trichloroethene | increases methylation | ISO | Gcnt3 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased methylation of GCNT3 gene | CTD | PMID:27618143 | triptonide | decreases expression | EXP | | 6480464 | triptonide results in decreased expression of GCNT3 mRNA | CTD | PMID:33045310 | tris(2-butoxyethyl) phosphate | affects expression | ISO | GCNT3 (Homo sapiens) | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of GCNT3 mRNA | CTD | PMID:29024780 | valproic acid | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of GCNT3 mRNA | CTD | PMID:29154799 | zoledronic acid | increases expression | ISO | GCNT3 (Homo sapiens) | 6480464 | zoledronic acid results in increased expression of GCNT3 mRNA | CTD | PMID:24714768 and PMID:25596134 | |